Treatment Indications: correction of fine to moderate facial wrinkles, superficial contour irregularities, and mild tissue depression;, delicate volumization in thin-skinned areas (e.g., periorbital zone, fine perioral lines);, improvement of skin texture and subtle contour refinement requiring a low‑density, highly malleable gel.
Release form: 1 × 1.0 mL pre‑filled syringe
Compound: cross‑linked hyaluronic acid (non‑animal origin, produced via biofermentation), lidocaine hydrochloride, phosphate‑buffered saline solution.
Concentration of GC: 20 mg/mL
Lidocaine: 0,3%
Indications: superficial dermal correction, fine line smoothing,, delicate zone contouring (including under‑eye hollows and fine lip border definition),, mild volume restoration where a soft, cohesive gel with low storage modulus (G’) is required.